Muscat: This initiative marks a significant leap in diagnosing diseases and crafting personalized treatments, setting a new benchmark for medical innovation in Oman.
Professor Dr Khalid bin Humaid Al Rasadi, Director of the Medical Research Center at Sultan Qaboos University, highlighted the program’s dual significance: as a vital healthcare advancement and as a matter of national security. “Genetic, biological samples and genomic data are vital and important aspects as they constitute national security content, as the program will contribute to setting policies to secure data, regulations and ethical standards for collecting, analyzing and using data in a manner that ensures data confidentiality and the privacy and rights of the individual and society,” he told Oman News Agency (ONA).
The program aims to establish a comprehensive national genomic database, paving the way for advanced research, local expertise in genomics and bioinformatics, and fostering a knowledge economy in biotechnology. It is expected to yield significant healthcare benefits by enabling genetic testing programs for rare diseases, heart and arterial conditions, diabetes, and cancer.
Read More
- Dhofar Municipality tightens licensing rules for 2026 Khareef season activities
- Oman condemns attacks on Bahrain and Kuwait
- Oman’s OMIFCO sees no impact from regional tensions, exports continue uninterrupted, says CEO
- Oman records season’s highest temperature as Mahout hits 50°C
- Oman records nearly 14,000 Hajj pilgrims in 2026; Muscat tops governorates
Dr Al Rasadi emphasized the transformative potential of precision medicine, which integrates genomic, clinical, and behavioural data to enhance disease diagnosis and treatment. Early detection and preventive measures for genetic conditions will improve public health outcomes and significantly reduce healthcare costs.
On the research front, the program will expand studies into rare and common genetic conditions like familial hereditary cholesterol disease and type 2 diabetes, leading to innovative diagnostic tools and treatments. It will also position Oman as a global leader in genome research.
Ethical considerations are at the forefront, with legislation being developed to regulate the use of genomic data in line with international standards. This ensures privacy and fosters public confidence in the program.
Professor Dr Khalid bin Humaid Al-Rasadi, Director of the Medical Research Center at Sultan Qaboos University, stressed that there are many potential benefits for individuals and society as a whole from the National Genome and Human Data Program, including enhancing community confidence through transparency in dealing with genomic data. He also focused on respecting individuals’ privacy, encouraging them to participate in surveys, examinations and genomic research, and enhancing their understanding of their role in preventing genetic diseases by adopting healthy lifestyles based on genetic knowledge, such as appropriate diets and customized exercises based on their genetic makeup.





